Direct Oral Anticoagulants and the Patient-Reported Outcomes

Synthesis and Advances

Research output: Chapter in Book/Report/Conference proceedingEntry for encyclopedia/dictionary

Abstract

Anticoagulation treatment with warfarin has been the gold standard of therapy for patients with atrial fibrillation to prevent stroke and for the treatment and prevention of venous thromboembolism. The development of direct oral anticoagulant agents over the past 10 years has created a shift in traditional management of these conditions. These new agents do not retain the pharmacokinetic and pharmacodynamic challenges associated with warfarin and do not require intensive blood monitoring and dose adjustment. Analyzing patient-reported outcomes incorporating patient satisfaction, adherence, compliance, and health-related quality of life gives prescribers and clinical practitioners an understanding of the patient perspectives of using DOACs. This article will focus on the patient-reported outcomes related to the DOAC treatment.
Original languageEnglish
Title of host publicationEncyclopedia of Pharmacy Practice and Clinical Pharmacy
EditorsZaheer Ud-Din Babar
PublisherElsevier
Pages898-908
Number of pages11
Volume3A
EditionFirst
ISBN (Electronic)9780128127360
ISBN (Print)9780128127353
Publication statusPublished - 20 Jun 2019

Fingerprint

Anticoagulants
Warfarin
Social Adjustment
Venous Thromboembolism
Therapeutics
Patient Compliance
Patient Satisfaction
Atrial Fibrillation
Compliance
Pharmacokinetics
Stroke
Quality of Life
Patient Reported Outcome Measures

Cite this

Afzal, S., Hasan, S. S., & Babar, Z-U-D. (2019). Direct Oral Anticoagulants and the Patient-Reported Outcomes: Synthesis and Advances. In Z. U-D. Babar (Ed.), Encyclopedia of Pharmacy Practice and Clinical Pharmacy (First ed., Vol. 3A, pp. 898-908). Elsevier.
Afzal, Saima ; Hasan, Syed Shahzad ; Babar, Zaheer-Ud-Din. / Direct Oral Anticoagulants and the Patient-Reported Outcomes : Synthesis and Advances. Encyclopedia of Pharmacy Practice and Clinical Pharmacy. editor / Zaheer Ud-Din Babar. Vol. 3A First. ed. Elsevier, 2019. pp. 898-908
@inbook{42ce0fe1e5df4d359ad6bedb30eae3d9,
title = "Direct Oral Anticoagulants and the Patient-Reported Outcomes: Synthesis and Advances",
abstract = "Anticoagulation treatment with warfarin has been the gold standard of therapy for patients with atrial fibrillation to prevent stroke and for the treatment and prevention of venous thromboembolism. The development of direct oral anticoagulant agents over the past 10 years has created a shift in traditional management of these conditions. These new agents do not retain the pharmacokinetic and pharmacodynamic challenges associated with warfarin and do not require intensive blood monitoring and dose adjustment. Analyzing patient-reported outcomes incorporating patient satisfaction, adherence, compliance, and health-related quality of life gives prescribers and clinical practitioners an understanding of the patient perspectives of using DOACs. This article will focus on the patient-reported outcomes related to the DOAC treatment.",
author = "Saima Afzal and Hasan, {Syed Shahzad} and Zaheer-Ud-Din Babar",
year = "2019",
month = "6",
day = "20",
language = "English",
isbn = "9780128127353",
volume = "3A",
pages = "898--908",
editor = "Babar, {Zaheer Ud-Din}",
booktitle = "Encyclopedia of Pharmacy Practice and Clinical Pharmacy",
publisher = "Elsevier",
edition = "First",

}

Afzal, S, Hasan, SS & Babar, Z-U-D 2019, Direct Oral Anticoagulants and the Patient-Reported Outcomes: Synthesis and Advances. in ZU-D Babar (ed.), Encyclopedia of Pharmacy Practice and Clinical Pharmacy. First edn, vol. 3A, Elsevier, pp. 898-908.

Direct Oral Anticoagulants and the Patient-Reported Outcomes : Synthesis and Advances. / Afzal, Saima; Hasan, Syed Shahzad; Babar, Zaheer-Ud-Din.

Encyclopedia of Pharmacy Practice and Clinical Pharmacy. ed. / Zaheer Ud-Din Babar. Vol. 3A First. ed. Elsevier, 2019. p. 898-908.

Research output: Chapter in Book/Report/Conference proceedingEntry for encyclopedia/dictionary

TY - CHAP

T1 - Direct Oral Anticoagulants and the Patient-Reported Outcomes

T2 - Synthesis and Advances

AU - Afzal, Saima

AU - Hasan, Syed Shahzad

AU - Babar, Zaheer-Ud-Din

PY - 2019/6/20

Y1 - 2019/6/20

N2 - Anticoagulation treatment with warfarin has been the gold standard of therapy for patients with atrial fibrillation to prevent stroke and for the treatment and prevention of venous thromboembolism. The development of direct oral anticoagulant agents over the past 10 years has created a shift in traditional management of these conditions. These new agents do not retain the pharmacokinetic and pharmacodynamic challenges associated with warfarin and do not require intensive blood monitoring and dose adjustment. Analyzing patient-reported outcomes incorporating patient satisfaction, adherence, compliance, and health-related quality of life gives prescribers and clinical practitioners an understanding of the patient perspectives of using DOACs. This article will focus on the patient-reported outcomes related to the DOAC treatment.

AB - Anticoagulation treatment with warfarin has been the gold standard of therapy for patients with atrial fibrillation to prevent stroke and for the treatment and prevention of venous thromboembolism. The development of direct oral anticoagulant agents over the past 10 years has created a shift in traditional management of these conditions. These new agents do not retain the pharmacokinetic and pharmacodynamic challenges associated with warfarin and do not require intensive blood monitoring and dose adjustment. Analyzing patient-reported outcomes incorporating patient satisfaction, adherence, compliance, and health-related quality of life gives prescribers and clinical practitioners an understanding of the patient perspectives of using DOACs. This article will focus on the patient-reported outcomes related to the DOAC treatment.

UR - https://www.elsevier.com/books/encyclopedia-of-pharmacy-practice-and-clinical-pharmacy/babar/978-0-12-812735-3

M3 - Entry for encyclopedia/dictionary

SN - 9780128127353

VL - 3A

SP - 898

EP - 908

BT - Encyclopedia of Pharmacy Practice and Clinical Pharmacy

A2 - Babar, Zaheer Ud-Din

PB - Elsevier

ER -

Afzal S, Hasan SS, Babar Z-U-D. Direct Oral Anticoagulants and the Patient-Reported Outcomes: Synthesis and Advances. In Babar ZU-D, editor, Encyclopedia of Pharmacy Practice and Clinical Pharmacy. First ed. Vol. 3A. Elsevier. 2019. p. 898-908